Shopping Cart
Remove All
Your shopping cart is currently empty
DPP-4-IN-17 is an orally active and selective inhibitor of dipeptidyl peptidase-4 (DPP-4) with an IC50 value of 0.12 nM. It increases the enzyme's Km value (75.73 μM compared to the substrate alone at 27.18 μM) and reduces catalytic efficiency. In Streptozotocin (STZ)/Nicotinamide (NA)-induced diabetic rats, DPP-4-IN-17 lowers blood glucose levels and reverses weight loss. This compound is useful for research in type 2 diabetes (T2DM).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | DPP-4-IN-17 is an orally active and selective inhibitor of dipeptidyl peptidase-4 (DPP-4) with an IC50 value of 0.12 nM. It increases the enzyme's Km value (75.73 μM compared to the substrate alone at 27.18 μM) and reduces catalytic efficiency. In Streptozotocin (STZ)/Nicotinamide (NA)-induced diabetic rats, DPP-4-IN-17 lowers blood glucose levels and reverses weight loss. This compound is useful for research in type 2 diabetes (T2DM). |
| Targets&IC50 | DPP4:0.12 nM |
| In vitro | DPP-4-IN-17 (Compound 8) functions as a competitive DPP-4 inhibitor, increasing the K m value from 27.18 μM to 75.73 μM, while also reducing catalytic efficiency. |
| In vivo | DPP-4-IN-17 (Compound 8), administered orally at a dose of 10-40 mg/kg once daily for 21 days, significantly reduces blood glucose levels and reverses weight loss in Streptozotocin (STZ) / Nicotinamide (NA) induced diabetic Wistar rats. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.